Vibrio vulnificus, an opportunistic human pathogen, produces cyclo-(l-Phe-l-Pro) (cFP), which serves as a signaling molecule controlling the ToxR-dependent expression of innate bacterial genes, and also as a virulence factor eliciting pathogenic effects on human cells by enhancing intracellular reactive oxygen species levels. We found that cFP facilitated the protection of V. vulnificus against hydrogen peroxide.
KEYWORDS: Vibrio vulnificus, cyclo-(l-Phe-l-Pro), quorum sensing, oxidative stress, hydroperoxidase, LeuO, RpoS, vHUαβ, HU
ABSTRACT
Vibrio vulnificus, an opportunistic human pathogen, produces cyclo-(l-Phe-l-Pro) (cFP), which serves as a signaling molecule controlling the ToxR-dependent expression of innate bacterial genes, and also as a virulence factor eliciting pathogenic effects on human cells by enhancing intracellular reactive oxygen species levels. We found that cFP facilitated the protection of V. vulnificus against hydrogen peroxide. At a concentration of 1 mM, cFP enhanced the level of the transcriptional regulator RpoS, which in turn induced expression of katG, encoding hydroperoxidase I, an enzyme that detoxifies H2O2 to overcome oxidative stress. We found that cFP upregulated the transcription of the histone-like proteins vHUα and vHUβ through the cFP-dependent regulator LeuO. LeuO binds directly to upstream regions of vhuA and vhuB to enhance transcription. vHUα and vHUβ then enhance the level of RpoS posttranscriptionally by stabilizing the mRNA. This cFP-mediated ToxR-LeuO-vHUαβ-RpoS pathway also upregulates genes known to be members of the RpoS regulon, suggesting that cFP acts as a cue for the signaling pathway responsible for both the RpoS and the LeuO regulons. Taken together, this study shows that cFP plays an important role as a virulence factor, as well as a signal for the protection of the cognate pathogen.
INTRODUCTION
When infecting a host, bacterial pathogens encounter harsh environmental hazards, such as host defense systems, restricted access to nutrients, and oxidative stress. Generally, these conditions have a negative effect on bacterial proliferation and survival within the host. To overcome such challenges, bacteria have evolved various defense mechanisms (1). Many of these defense mechanisms are regulated by the alternative sigma factor RpoS (σS), which is the master regulator of the general stress response (2, 3). RpoS is conserved among the gammaproteobacteria and is involved in the regulation of both virulence factors and stress responses in pathogenic bacteria, such as Vibrio vulnificus (4–7), a Gram-negative opportunistic pathogenic bacterium that causes septicemia and wound infections in humans (8–11). An RpoS-deficient mutant of V. vulnificus does not survive well under diverse environmental stresses, including exposure to hydrogen peroxide (H2O2), hyperosmolarity, and acidic conditions (7).
Cyclic dipeptides, also known as 2,5-diketopiperazines (DKPs), are naturally produced by animals, plants, fungi, and bacteria (12, 13). Most DKPs originate as by-products of fermentation or food processing (12), and there are also numerous endogenous DKPs that are produced by both animals and plants (12, 13). It has been reported that DKPs have antiviral, antibacterial, and antitumor activities (14–20). Cyclo-(l-phenylalanine-l-proline) (cFP) is produced by Vibrio spp. and is known to be a quorum-sensing signal that modulates the expression of the outer membrane protein OmpU in a ToxR-dependent manner (21–23). ToxR is an inner membrane protein present in pathogenic Vibrio spp. (24). In response to environmental signals that are not well understood, ToxR activates the ToxT regulon, stimulating expression of ctxAB (cholera toxin), TCP (the toxin-coregulated pilus), ompT (outer membrane porin), and accessory colonization factor (ACF), a protein that has been shown to repress the type VI secretion system in Vibrio cholerae (24–27). OmpU is associated with Vibrio sp. pathogenicity, conferring resistance to antibacterial peptides and bile acid, as well as aiding attachment to host cells (28–30).
Recently, it has been reported that cFP from V. vulnificus affects the NF-κB pathway in lipopolysaccharide (LPS)-stimulated monocyte/macrophage cell lines and also induces DNA double-strand breaks in a human intestinal cell line by increasing intracellular reactive oxygen species (ROS) (31, 32). ROS molecules generated in the host may harm the invading bacterial pathogen, and therefore, the pathogen must employ various means to detoxify these molecules (33). One of these mechanisms involves the enzyme KatG (hydroperoxidase I), which detoxifies H2O2 by converting it to H2O and O2 (34). We hypothesized that cFP may also be important in the response to ROS, and we investigated the protective effects of cFP in V. vulnificus, specifically through the expression of KatG. Our findings showed that cFP induces the expression of genes associated with detoxification of ROS via the master regulator RpoS, and we further demonstrate a molecular mechanism underlying the regulation of this process.
RESULTS
cFP facilitates the survival of V. vulnificus under H2O2-induced oxidative stress conditions.
A recent study showed that cFP produced by V. vulnificus increases the intracellular levels of ROS in human cell lines, resulting in apoptosis (31, 32). This report led us to hypothesize that cFP may be associated with the response of V. vulnificus to oxidative stress, as well. To test this, we measured the survival rate of V. vulnificus under H2O2-induced stress conditions after supplementing cells with cFP that had been extracted from culture supernatants of either wild-type V. vulnificus (strain MO6-24/O) or V. vulnificus Δllc, a mutant MO6-24/O strain defective in cFP production (32) (Fig. 1A). cFP can be readily extracted from culture supernatant using ethyl acetate (21). Supplementing V. vulnificus with extracts from a stationary-phase culture supernatant resulted in a significantly increased survival rate. However, survival was not improved when cells were treated with extracts from either MO6-24/O grown to early exponential phase or from the Δllc mutant. These results suggest that the cFP produced in wild-type V. vulnificus while in stationary phase (21) enhances the survival of V. vulnificus under oxidative stress. We also assessed the survival of V. vulnificus in the presence of H2O2-induced ROS by supplementing with various concentrations (0 to 10 mM) of chemically synthesized cFP. As shown in Fig. 1B, treatment of peroxide-stressed wild-type V. vulnificus with up to 1 mM cFP, representing the physiological concentration of cFP in a culture supernatant of V. vulnificus at stationary phase (21), increased survival in a concentration-dependent manner. The relative CFU numbers in the presence of 1 mM cFP were at least 5-fold higher than without cFP (Fig. 1B, left graph). However, when cFP was added at higher concentrations, survivability decreased drastically, and at 10 mM, CFU were barely detectable. In contrast, under non-oxidative stress conditions (no H2O2 treatment), the survival of V. vulnificus was not influenced by cFP even at concentrations of 5 or 10 mM (Fig. 1B, right graph).
A previous study demonstrated that some DKPs, especially those derived from the cyclization of an amino acid with leucine, exhibit antioxidant activity due to their innate ability to scavenge radicals (35). We considered the possibility that enhancement of the survival of H2O2-treated V. vulnificus cells by cFP may also be due to the capability of cFP itself to scavenge radicals. We tested this by performing a DPPH (2,2-diphenyl-1-picrylhydrazyl) radical-scavenging assay, as described in Materials and Methods. Using l-ascorbic acid as a positive control (36), the DPPH radical-scavenging activity was measured in the presence of several concentrations of cFP. While l-ascorbic acid showed antioxidant activity in a concentration-dependent manner, cFP did not exhibit any significant antioxidant activity (see Fig. S1 in the supplemental material). This result suggested that cFP cannot reduce intracellular ROS levels through direct molecular interactions; rather, it may enhance the survivability of V. vulnificus by affecting signaling pathways involved in oxidation stress survival.
cFP induces the expression of katG via RpoS.
KatG (hydroperoxidase I) is a key enzyme responsible for H2O2 detoxification, and it has been reported that expression of katG is regulated by RpoS in V. vulnificus (34). We considered the possibility that cFP exerts an antioxidant effect by altering the expression of katG. To test this, we measured the effects of various cFP concentrations on katG expression levels using a katG-lacZ transcriptional reporter fusion (Fig. 2A) under 625 μM H2O2-induced oxidative conditions. Expression of katG in wild-type V. vulnificus MO6-24/O was about 1.7 times higher in the presence of 1 mM cFP than with 0 and 5 mM cFP. In contrast, in KPR101 (34), a V. vulnificus isotype with rpoS deleted, varying cFP concentrations had no effect. Introducing an rpoS clone back into the mutant restored the response to cFP. In the absence of H2O2, the expression of katG in the wild-type strain was not affected by cFP and was about half the level observed under H2O2-induced oxidative conditions, suggesting that H2O2 enhances katG expression, although to much less significant levels than cFP. We also quantitatively compared the survivability of MO6-24/O and KPR101 after treatment with 1 mM cFP, followed by 625 μM H2O2 (Fig. 2B). Consistent with the hypothesis that cFP affects katG transcription, cFP did not enhance survivability in KPR101, but 1 mM cFP dramatically increased the survivability of wild-type cells (Fig. 2B). These results indicate that cFP at 1 mM activates KatG expression under oxidative stress conditions via an RpoS-regulated pathway and that this activation is responsible for the increased survivability of V. vulnificus under oxidative stress conditions induced by H2O2.
cFP activates the expression of rpoS at the posttranscriptional level.
We assessed the effect of cFP on the level of rpoS transcription using an rpoS-lacZ transcriptional fusion (Fig. 3) and growing cells in AB (autoinducer bioassay) minimal medium. In AB minimal medium, even though growth of V. vulnificus is somewhat limited and cells reach stationary phase at an A600 of 0.2, intracellular biosynthesis of cFP is lower (unpublished data) and the effects of exogenously supplemented cFP are more evident. β-Galactosidase expression of the rpoS-lacZ transcriptional fusion in the presence of cFP at three different concentrations (0, 1, and 5 mM) did not differ significantly (Fig. 3A). RpoS is a central regulator of general stress responses and is controlled by various factors at the transcriptional, translational, and posttranslational levels (2, 37). We measured the levels of RpoS translation through Western hybridization of cell extracts at early stationary phase (A600 = 0.2) and mid-stationary phase (A600 = 0.3) using polyclonal rabbit antisera against purified RpoS. We observed about 1.5-fold higher expression levels of RpoS in the presence of 1 mM cFP than when cFP was added at 0 mM or 5 mM (Fig. 3B), indicating that the presence of cFP affected rpoS at a posttranscriptional or translational level.
vHUαβ are involved in the enhancement of RpoS expression elicited by cFP.
To determine how cFP affects the expression of RpoS, we examined each of the various posttranscriptional and proteolysis factors associated with intracellular RpoS levels. It has been documented that expression of RpoS is stimulated or stabilized by HUαβ and Hfq and repressed by H-NS at the posttranscriptional level in other bacterial species (2, 37). It has also been previously reported that RpoS is degraded by ClpX, which in turn is regulated by RssB (3, 37). We assessed the effect of cFP on the expression of these various factors using quantitative real-time PCR (qRT-PCR) (Fig. 4A). The results showed that expression level patterns of vhuA and vhuB (Vibrio HUα and -β genes) overlapped with that of katG; vhuA and vhuB expression levels were significantly enhanced with 1 mM cFP and decreased with 5 mM cFP (Fig. 4A). Expression levels of clpX, hfq, and hns were not significantly affected by cFP. Expression of rssB was significantly decreased in the presence of 5 mM cFP but was not affected by 1 mM cFP. For dksA, expression levels were enhanced by the addition of 1 mM cFP and were even higher with 5 mM cFP. These results suggest that DksA, vHUα, and vHUβ are all involved in the cFP-dependent enhanced expression of rpoS in V. vulnificus. Our previous transcriptomic analysis of genes affected by cFP in wild-type V. vulnificus showed that transcription levels of vHUα and -β were increased in the presence of cFP (38). Therefore, we focused on vHUα and -β, which showed a cFP-dependent expression pattern similar to that of RpoS, for further studies. qRT-PCR was used to compare levels of rpoS transcripts in wild-type V. vulnificus and an isotype with deletions of the vhuAB genes (Fig. 4B). The expression level of rpoS was higher in the presence of 1 mM cFP in wild-type cells. However, in the vhuAB deletion mutant, the basal level of RpoS expression without cFP was just half the wild-type level, and addition of cFP had no significant effect. Complementation of the vhuAB deletion mutant with exogenous vhuAB on a plasmid restored expression of rpoS when 1 mM cFP was supplemented. This suggests that in V. vulnificus, vHUαβ proteins are required for a basal level of rpoS expression in the absence of cFP and are required for cFP-mediated induction of rpoS expression.
The cytoplasmic regulator LeuO is responsible for the cFP-dependent induction of vhuAB expression.
The cytoplasmic LysR-type regulator LeuO is involved in the cFP signaling pathway in both V. vulnificus (our unpublished data) and V. cholerae (23). We used qRT-PCR to examine the possibility that LeuO is involved in the cFP-signaling regulation of rpoS by comparing transcription levels of rpoS in the wild type, a leuO deletion mutant, and a leuO vhuAB triple-deletion mutant (Fig. 5A). Deletion of leuO abolished the cFP-mediated induction of rpoS, and introduction of a leuO clone restored induction in the presence of 1 mM cFP. In a leuO vhuAB triple-deletion mutant, expression of rpoS was not induced by cFP, and rpoS expression levels were significantly lower than in the wild type. Introduction of either leuO or vhuAB independently into the triple mutant failed to restore cFP induction. However, when all three genes were reintroduced, rpoS expression was restored. These results suggested that LeuO and vHUαβ are both involved in cFP signaling regulation of rpoS expression, and this led us to hypothesize that cFP signaling is transduced to vhuAB through LeuO. To test this, the effect of LeuO on vhuA and vhuB transcription levels was quantitatively measured using vhuA-lacZ and vhuB-lacZ transcriptional fusions (Fig. 5B). Expression of β-galactosidase from each of these lacZ fusions in a wild-type strain increased by up to about 1.5-fold in the presence of 1 mM cFP. In contrast, in a leuO deletion mutant, transcription was not affected by cFP. Introduction of an exogenous leuO clone into the leuO deletion mutant restored the cFP-induced expression of vhuA and vhuB. LeuO is a LysR family transcriptional regulator that binds directly to the promoter of target genes (39). To determine whether the effect of LeuO on expression of vHUα and vHUβ is mediated by direct binding to cis-acting elements in upstream regions of the coding genes, gel shift assays were performed using a recombinant LeuO protein (39) and a DNA probe, including the upstream regions of vhuA and vhuB (Fig. 5C). LeuO binds to upstream regions of both vhuA and vhuB in a concentration-dependent manner. These results show that LeuO regulates expression of vhuA and vhuB by binding directly to their cis-acting elements in upstream regions.
Expression of leuO is activated by cFP in a concentration-dependent manner.
The above-described results suggest that LeuO regulates the expression of vhuA and vhuB and that this expression is induced by 1 mM cFP, but not with 5 mM cFP. Therefore, we predicted that leuO expression would follow a similar pattern. We used a leuO-lacZ transcriptional reporter fusion to measure expression of leuO in cells grown in media containing cFP at 0, 1, and 5 mM. Surprisingly, leuO was expressed at higher levels with 5 mM cFP than it was with 1 mM (Fig. 6A). We then measured the transcription of vhuA and vhuB using lacZ fusions in a ΔleuO strain harboring an arabinose-inducible leuO overexpression vector (Fig. 6B). The level of vhuA transcription increased in proportion to the arabinose concentration up to 0.01% arabinose. At higher arabinose concentrations, however, vhuA transcription levels started to decrease. The expression of vhuB followed a similar pattern. These results suggest that expression of vhuA and vhuB reaches a maximal level at a particular intracellular concentration of LeuO and then decreases at higher LeuO concentrations.
RpoS mRNA is stabilized by LeuO-vHUαβ signal transduction elicited by cFP.
The above-mentioned result suggests that regulation of RpoS expression by cFP is at the posttranscriptional level. We assessed the stability of the rpoS mRNA after treatment with cFP in both wild-type V. vulnificus and a vhuAB deletion mutant by treating cells with cFP and then adding rifampin to interrupt transcription. The relative rpoS mRNA levels in each of these strains were assessed by qRT-PCR in a time course experiment (Fig. 7A). The half-life of rpoS mRNA in wild-type V. vulnificus grown in the presence of 1 mM cFP was about 29.8 min, and those of cells grown either without cFP or with 5 mM cFP were 16.0 and 16.5 min, respectively. In a vhuAB deletion mutant, the half-life of rpoS mRNA was much shorter, at 2.7 (0 mM cFP), 1.9 (1 mM cFP), and 5.2 (5 mM cFP) min. RpoS protein levels were higher in wild-type V. vulnificus after treatment with cFP, but in the vhuAB deletion mutant, even though overall levels were lower, there was no increase in the presence of 1 mM cFP (Fig. 7B). Complementation of the vhuAB deletion mutant with exogenous vhuAB on a plasmid restored expression of rpoS when supplemented with 1 mM cFP. These results indicate that 1 mM cFP enhances RpoS expression at the posttranscriptional level, most likely by enhancing mRNA stability through the activity of vHUαβ.
cFP affects the expression of the RpoS regulon.
We showed that the expression of katG is increased in the presence of 1 mM cFP due to regulation of rpoS expression. The next question was whether cFP influenced the expression of other genes in V. vulnificus previously reported to be regulated by RpoS, including aldA, gabD, and vvpE (40, 41). These genes encode an aldehyde dehydrogenase, a succinate-semialdehyde dehydrogenase, and a metalloprotease, respectively. Expression levels of the genes in wild-type V. vulnificus MO6-24/O and in the rpoS deletion isotype strain KPR101 after treatment with various concentrations of cFP were measured using qRT-PCR (Fig. 8). In wild-type cells, the expression of each gene was enhanced in the presence of 1 mM cFP. However, when 5 mM cFP was added, expression was not significantly different from that in cells with no cFP treatment. In contrast, in KPR101 cells, expression of the three genes did not increase significantly upon the addition of 1 mM cFP, suggesting that RpoS is required. To summarize, these results indicate that 1 mM cFP led to the increased expression of genes in the RpoS regulon.
Effects of cFP on the expression of leuO, vhuAB, and rpoS in V. cholerae and V. parahaemolyticus.
V. cholerae and Vibrio parahaemolyticus also produce cFP (21). In these related human pathogens, cFP modulates genes through ToxR (21), suggesting that, as in V. vulnificus, cFP may trigger expression of leuO, vhuAB, and rpoS. To test this assumption, the expression of each of the three genes in the presence of cFP at varying concentrations was assessed using qRT-PCR (Fig. 9). The expression pattern in V. cholerae was similar to that seen previously for V. vulnificus in that each of the three genes was expressed at the highest level in the presence of 0.5 mM cFP and then was lower at higher concentrations of cFP. However, a different pattern was observed for V. parahaemolyticus in that cFP had minimal effect on the expression of vhuAB, and expression of both rpoS and leuO increased gradually in a cFP-dependent manner (up to 5 mM cFP).
DISCUSSION
In this study, we showed that in V. vulnificus, the diketopiperazine compound cFP facilitates survival under H2O2 oxidative stress, not by direct antioxidant activity, but by upregulating hydroperoxidase through a complex signal transduction pathway that includes hierarchical regulatory components. It has been suggested that in wild-type V. vulnificus (MO6-24/O), which lacks the canonical homoserine lactone signal, cFP acts as a quorum-sensing signal in addition to autoinducer-2 (AI-2) (21, 22). This study, along with our previous study (28), describes the first example of a quorum-sensing signaling molecule that has a distinctly different second role as a direct virulence factor and an inducer of pathways that protect the pathogen from damage induced by the signal molecule in the host.
The direct effector of this cFP-associated antioxidant stress response is the hydroperoxidase KatG, while the regulator of this function is the alternative sigma factor RpoS (Fig. 2). RpoS is a master regulator of the general stress response in many bacteria, and its intracellular concentration is regulated by many factors at transcriptional, translational, and posttranslational levels (2, 3, 37). RpoS is regulated at the transcriptional level by factors including ArcAB, Crp, and (p)ppGpp (2, 3); at the translational level by factors including Hfq and small RNAs (e.g., DsrA, RprA, and ArcZ) (2, 37); and at the regulatory level by HN-S, OxyS, HUαβ, DksA, CsdA, and CspCE (2, 3). RNase III is important for the stability of RpoS mRNA (2) and proteolytic processing, and along with numerous factors, such as ClpXP, RssB, and the antiadaptors IraPMD (required for the stability of RpoS by interfering with RssB activity), controls RpoS protein levels (3). Some of these factors enhance intracellular RpoS levels, while others reduce it. From our previous transcriptomic study (38), we identified factors affected by cFP in such a way that an increase in intracellular RpoS would be expected. Among the factors that influence RpoS, oxyS, arcZS, dsrA, and iraPDM are not found in the genome of V. vulnificus. In the presence of cFP, expression levels of relA and arcB and the gene encoding RNase III are not enhanced. However, expression levels of vhuAB and dksA, factors known to be required for the stabilization of RpoS mRNA, were higher in the presence of cFP. In the current study, qRT-PCR experiments confirmed that cFP induced the expression of these genes (Fig. 4A). DksA is known to activate translation of rpoS indirectly via Hfq (42). However, in our results, expression of Hfq was not significantly affected by cFP. Particularly interesting was the effect of cFP on the expression patterns of vhuAB, which followed a trend similar to that of katG. The observed results suggested that the histone-like proteins HUαβ are the regulatory components directly responsible for cFP-dependent regulation of RpoS, and hence, we focused on these factors for further studies.
The histone-like proteins HUαβ are known to be major components of nucleoid-associated proteins and are conserved in most bacteria (43). HUαβ can bind to DNA or RNA by recognizing a specific structure (44). Although functions associated with DNA binding have been studied extensively (45–47), a role in RNA binding is not understood. HUαβ have been shown to bind to rpoS and dsrA RNAs and some noncoding RNAs (44, 48, 49). In Escherichia coli, HUαβ bind to rpoS mRNA specifically and stimulate translation but do not affect stability (48). Therefore, it has been suggested that HUαβ modify the RNA secondary structure to facilitate ribosome binding or, alternatively, modulate binding of other factors, such as Hfq or H-NS, or both. However, vHUαβ appear to affect the rpoS mRNA stability in V. vulnificus (Fig. 4B and 7A). How these proteins affect translational regulation of RpoS in V. vulnificus remains to be elucidated.
Currently, it is not clear why we observed lower expression of katG in the presence of 5 mM cFP than with 1 mM cFP (Fig. 2). The expression of leuO is increased by cFP in a concentration-dependent manner (Fig. 6A). However, the expression of vhuAB, which is just downstream of LeuO in the signaling pathway, was lower at 5 mM cFP, and increased levels of LeuO resulted in a decrease in vhuAB above a certain concentration of cFP, suggesting that LeuO induces the expression of vhuAB only to a certain level and that the effect is abolished above that level. A similar LeuO induction pattern was observed in Salmonella enterica (50, 51). Multiple binding sites for LeuO in the upstream regions of vhuAB, as suggested by electrophoretic mobility shift assays (Fig. 5C), are thought to be important for this regulation. Higher concentrations of cFP could be toxic to V. vulnificus, and cFP, together with H2O2, may be synergistically harmful to the pathogen (Fig. 1B). However, the physiological concentration of cFP in a culture supernatant of V. vulnificus at stationary phase is 0.7 to 1.0 mM (21), which, as shown in this study, is optimal for conferring resistance to H2O2. It is unlikely that V. vulnificus encounters a higher concentration of cFP under conditions that prevail in natural habitats.
The culture conditions used for growth of V. vulnificus in this study may not precisely mimic the conditions the pathogen encounters in a host, and the precise concentrations of cFP produced by the pathogen while in the host are unknown. However, our previous studies showed that infection of human cells with V. vulnificus led to physiological changes that were similar to those we observed when cells were treated with 1 mM exogenous synthetic cFP (33, 34), suggesting that our in vitro conditions accurately mimic the cFP produced by V. vulnificus. Nevertheless, further study is necessary to determine whether the results from this study represent biological events that occur during pathogen infection.
We extended our study to the related important pathogens V. cholerae, which is the causative agent of cholera, and V. parahaemolyticus, which causes gastrointestinal illness in humans. The effect of cFP on V. cholerae was similar to that observed for V. vulnificus. In V. cholerae, LeuO is upregulated by cFP (23) and then represses aphA, a gene encoding the first in a cascade of regulatory proteins that eventually affects levels of both cholera toxin and toxin-related pilus. It is likely that the pathogen also harbors a cFP signaling pathway for the regulation of catalase similar to that of V. vulnificus. In contrast, V. parahaemolyticus employs a cFP-associated signal transduction pathway at least partly distinct from those of the other two Vibrio species. Expression of HUαβ does not appear to be affected by exogenous cFP in this pathogen. Expression of LeuO and RpoS are induced by cFP, but unlike V. vulnificus and V. cholerae, expression levels increased with increasing cFP concentrations in the range that was tested. The details of cFP-mediated signaling in V. parahaemolyticus remain to be elucidated.
In this study, we describe a newly identified cFP-mediated signal transduction pathway that includes ToxR, LeuO, HUαβ, and RpoS (Fig. 10). Each of these components plays a role in other signaling pathways in addition to the one proposed here. For example, LeuO controls the expression of ompU, encoding a porin (21), and vvpS, encoding a virulence protease (39). It is well known that HUαβ is associated with the regulation of various genes through the maintenance of nucleoid structure and is thereby linked to the regulation of repair and recombination of DNA, as well (43). As an alternative sigma factor, RpoS is responsible for the transcription of numerous target genes associated with stationary-phase physiology. Resistance to hydrogen peroxide appears to be only one part of the complex and extensive regulatory circuits that depend upon cFP as a signaling molecule. The biological roles of this diffusible compound, particularly in the context of pathogenicity, need to be further clarified through extensive investigation of additional target genes.
MATERIALS AND METHODS
Strains, plasmids, culture conditions, and primers used in this study.
The strains and plasmids used in this study are listed in Table S1 in the supplemental material. E. coli strains were cultured in Luria-Bertani (LB) broth supplemented with appropriate antibiotics at 37°C. V. vulnificus strains were cultured in LB medium, AB minimal medium (52), or thiosulfate citrate bile salt sucrose (TCBS) agar at 30°C. All the DNA oligonucleotide primers employed in this study are listed in Table S2 in the supplemental material.
Determination of the effect of hydrogen peroxide on CFU of V. vulnificus.
Overnight cultures of V. vulnificus strains were subcultured to fresh LB medium containing increasing concentrations of cFP (0.0, 0.5, 1.0, 2.5, 5.0, and 10 mM). When the A600 of the culture reached exponential phase (about 0.3 to 0.5), cells were harvested, washed twice, and resuspended in artificial seawater (ASW) (34) containing the respective concentrations of cFP and hydrogen peroxide (0.625 mM) to an A600 of approximately 0.1. The cells were grown at 30°C for 60 min, and aliquots were spotted on LB agar plates to determine the number of CFU.
Construction of the vhuA and vhuB deletion mutants and cloning of vhuA and vhuB.
To construct a deletion mutant of vhuA, a 693-bp DNA fragment of the upstream region and a 700-bp DNA fragment of the downstream region of the vhuA gene were amplified using primers vhuα-koF1 and vhuα-koB1 and primers vhuα-koF2 and vhuα-koB2, respectively. To construct the vhuB deletion mutant, a 751-bp DNA fragment of the upstream region and a 653-bp DNA fragment of the downstream region of vhuB were amplified using primers vhuβ-koF1 and vhuβ-koB1 and primers vhuβ-koF2 and vhuβ-koB2, respectively. After confirming the sequences, each fragment was cloned to a SalI-digested pDM4 plasmid using an In-fusion HD cloning kit (Clontech Laboratories, TaKaRa Bio, Inc., Shiga, Japan) to generate pDM-vhuA KO and pDM-vhuB KO, respectively. Then, each plasmid was introduced into E. coli strain S17-1 λ-pir (53) to be mobilized into V. vulnificus MO6-24/O by conjugation. Double-crossover selection to construct a deletion mutant of vhuA and vhuB in the chromosome was performed as described previously (54). First, the 526-bp DNA fragment comprising the promoter region and the coding region of vhuB was amplified using primers pRK-vhuβ-comF and pRK-vhuβ-comB. The resulting product was cloned into PstI-digested pRK415 (55) to generate pRK-vhuB. Next, the 535-bp DNA fragment, including the coding region and promoter region of vhuA, was amplified using primers pRK-vhuα-comF and pRK-vhuα-comB. The amplified fragment was cloned into EcoRI-digested pRK-vhuB to generate pRK-vhuAB. To construct pBBR12-vhuAB, the 1,061-bp DNA fragment comprising vhuAB was amplified from pRK-vhuAB using primers pBBR12-vhucomF and pBBR12-vhucomB. The amplified fragment was cloned into BamHI- and EcoRI-digested pBBR1-MCS2 (56) to generate pBBR12-vhuAB. pRK-vhuAB and pBBR12-vhuAB were introduced into E. coli strain S17-1 λ-pir to be mobilized into a vhuAB deletion mutant strain of V. vulnificus by conjugation.
Construction of pMZtc for single crossover to generate lacZ transcriptional fusions in the chromosome.
Portions (3.28 kbp) of the promoterless lacZ fragments were amplified by PCR from pRKΩlacZ (21) using the primers pDM4-lacZF and pDM4-lacZB. After confirming the sequences, each amplified fragment was cloned into SacI-digested pDM4 using the In-fusion HD cloning kit to generate pMZtc.
Construction of lacZ reporter fusions to katG, rpoS, vhuA, vhuB, and leuO.
lacZ trancriptional fusions to katG, RpoS, vhuA, vhuB, and leuO were constructed as follows. The 562-bp upstream region (−515 to +47 relative to the translation start site) of katG, the 577-bp upstream region (−500 to +77 relative to the translation start site) of vhuA, the 552-bp upstream region (−478 to +74 relative to the translation start site) of vhuB, and the 498-bp upstream region (−445 to +53 relative to the translation start site) of rpoS were amplified by PCR using primers katG-tcF and katG-tcB, primers vhuα-scF and vhuα-scB, primers vhuβ-scF and vhuβ-scB, and primers RpoS-scF and RpoS-sctcB, respectively. Amplified fragments of each gene were cloned into the BglII-digested pMZtc plasmid using the In-fusion HD cloning kit to generate pMZtc-katG, pMZtc-vhuA, pMZtc-vhuB, and pMZtc-rpoS, respectively. To construct a leuO-lacZ fusion, the 1,241-bp region (−1088 to +153 relative to the translation start site) of leuO was amplified by PCR using the primers leuO-scF and leuO-scB and cloned into the pGEM-T-Easy vector (Promega, Madison, WI). The resulting plasmid was digested with XhoI and XbaI, and the fragment was cloned into pMZtc to generate pMZtc-leuO. These constructs were conjugated into the V. vulnificus MO6-24/O wild type or other strains, and a single crossover was obtained by selecting chloramphenicol-resistant colonies.
To construct lacZ translational reporter fusions to rpoS, the 1,387-bp upstream region (−645 to +742 relative to the translation start site) of rpoS and the 3,108-bp lacZ gene (+26 to +3,133, relative to the translation start site) of miniTn5-lacZ1 (57) were amplified by PCR using primers pRZtl-rpoSF and pRZtl-rpoSB and primers rpoS-lacZtlF and rpoS-lacZtlB. Amplified fragments of each gene were cloned into the pstI-digested pRK415 vector (55) to generate pRZtl-rpoS using the In-fusion HD cloning kit. The resulting vector contained an in-frame lacZ fusion to rpoS.
β-Galactosidase assay.
β-Galactosidase activity from cells harboring the genes fused with lacZ described above was measured as described previously (58). Briefly, V. vulnificus strains were cultured overnight in LB medium and then washed and subcultured in fresh LB medium containing various concentrations of cFP. When the A600 of the culture reached exponential phase (about 0.3 to 0.5), the cells were washed and resuspended in AB broth (A600, ∼0.05) containing various concentrations of cFP. β-Galactosidase activity was measured at 1-h intervals.
Cloning of leuO and construction of an arabinose-inducible LeuO system.
The 1,312-bp DNA fragment comprising the promoter region and the coding region of leuO was amplified by PCR using primers leuO_comP_F_xhoI and leuO_comP_R_kpnI. The resulting product was cloned into XhoI- and KpnI-digested pBBR1-MCS2 (56) to construct pBBR12-leuO. The 957-bp DNA fragment of the leuO gene was amplified using primers BAD-leuOF and BAD-leuOB. The resulting fragment was cloned into pBAD-TOPO (Invitrogen, Thermo Fisher Scientific Inc., MA) to generate pBAD-leuO. A 2,700-bp DNA fragment including the ara promoter region fused to the promoterless leuO was amplified with primers BBR12-bad-leuOF and BBR12-bad-leuOB and cloned into the EcoRI-digested pBBR1-MCS2 vector (56) using the In-fusion HD cloning kit to generate pBBR12-leuO-ara.
Electrophoresis mobility shift assay.
Recombinant LeuO protein was expressed in E. coli BL21(DE3) harboring pRE1-leuO (39) and purified using His-Bind resin (Novagen). The 303-bp DNA fragment of the vhuA upstream region (−261 to +42 with respect to the translation start site) and the 259-bp DNA fragment of the vhuB upstream region (−214 to +45 with respect to the translation start site) were PCR amplified using primers vhuα-EMSAF and 32P-labeled vhuα-EMSAB and primers vhuβ-EMSAF and 32P-labeled vhuβ-EMSAB, respectively. For gel shift assays, 10 ng of the labeled probe was incubated with increasing amounts of purified LeuO protein (0 to 80 nM) in a 20-μl reaction mixture in binding buffer containing 10 mM Tris-HCl (pH 7.4), 10 mM KCl, 1 mM EDTA, 0.1 mM dithiothreitol (DTT), 50 μg/ml bovine serum albumin, 5% glycerol, and 1 μg poly(dI-dC) for 30 min at 37°C (39). The samples were resolved in a 6% neutral polyacrylamide gel. The gels were exposed to a BAS-MP 2040s IP plate (Fujifilm, Tokyo, Japan) and scanned using BAS-1500 (Fujifilm, Tokyo, Japan).
Purification of RpoS and Western blot hybridization.
A DNA fragment encoding 331 amino acids of RpoS was PCR amplified using primers rpoS-ndeI and rpoS-bamHI. The amplified fragment was subcloned into pET14b (Novagen, Madison, WI), which resulted in RpoS fused to a His tag at the N terminus. This construct was then transformed into E. coli BL21(DE3) (Novagen, Madison, WI) for expression of the recombinant RpoS. Purified RpoS was used for the production of polyclonal rabbit antisera (AbClon, Seoul, South Korea). For the analysis of the effect of cFP on RpoS expression, overnight cultures of V. vulnificus strains were subcultured to fresh LB medium containing appropriate concentrations of cFP. When the A600 of the culture reached exponential phase (about 0.3 to 0.5), the cells were washed and resuspended with AB broth containing the appropriate concentration of cFP. The cells were washed with phosphate-buffered saline (PBS), and 40 μg of each lysate was resolved by SDS-PAGE and transferred to a Hybond P membrane (GE Healthcare Life Sciences, Piscataway, NJ). The membrane was incubated with polyclonal rabbit antiserum against RpoS (1:2,000) and subsequently with goat anti-rabbit IgG-horseradish peroxidase (HRP) (1:2,000; Santa Cruz Biotechnology, Santa Cruz, CA). RpoS expression was visualized using ECL Western blotting detection reagent (GE Healthcare Life Sciences, Piscataway, NJ). The relative intensities of the bands were measured using Multi Gauge v. 3.0 software (Fujifilm, Tokyo, Japan). For a loading control, polyclonal rat antiserum against SidC (59) was used.
qRT-PCR analysis.
RNA was isolated from Vibrio species using an RNeasy minikit (Qiagen, CA, USA) and an RNase-Free DNase set (Qiagen, CA, USA). cDNA was synthesized from 1 μg of RNA using the PrimeScript RT reagent kit (TaKaRa Bio, Inc., Shiga, Japan), following the manufacturer's directions. cDNA (2 μl) was analyzed by qRT-PCR on a Light Cycler 480 II real-time PCR system (Roche Applied Science, Upper Bavaria, Germany). qRT-PCR was carried out in triplicate in a 96-well plate (Roche Applied Science) using the primers shown in Table S2 in the supplemental material. The gene encoding NAD-dependent glyceraldehyde-3-phosphatase of Vibrio species was used as an endogenous loading control for the reactions. Quantification was carried out using the Light Cycler 480 II real-time PCR system software program.
Supplementary Material
ACKNOWLEDGMENTS
This work was supported by grants from the National Research Foundation (NRF) of Korea funded by the Ministry of Science and ICT (2015M3C9A2054020 and 2017R1A2B2006966).
We declare that we have no conflict of interest regarding the contents of this article.
Footnotes
Supplemental material for this article may be found at https://doi.org/10.1128/IAI.00932-17.
REFERENCES
- 1.Guan N, Li J, Shin HD, Du G, Chen J, Liu L. 2017. Microbial response to environmental stresses: from fundamental mechanisms to practical applications. Appl Microbiol Biotechnol 101:3991–4008. doi: 10.1007/s00253-017-8264-y. [DOI] [PubMed] [Google Scholar]
- 2.Battesti A, Majdalani N, Gottesman S. 2011. The RpoS-mediated general stress response in Escherichia coli. Annu Rev Microbiol 65:189–213. doi: 10.1146/annurev-micro-090110-102946. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Landini P, Egli T, Wolf J, Lacour S. 2014. sigmaS, a major player in the response to environmental stresses in Escherichia coli: role, regulation and mechanisms of promoter recognition. Environ Microbiol Rep 6:1–13. doi: 10.1111/1758-2229.12112. [DOI] [PubMed] [Google Scholar]
- 4.Santander RD, Monte-Serrano M, Rodriguez-Herva JJ, Lopez-Solanilla E, Rodriguez-Palenzuela P, Biosca EG. 2014. Exploring new roles for the rpoS gene in the survival and virulence of the fire blight pathogen Erwinia amylovora. FEMS Microbiol Ecol 90:895–907. doi: 10.1111/1574-6941.12444. [DOI] [PubMed] [Google Scholar]
- 5.Yildiz FH, Schoolnik GK. 1998. Role of rpoS in stress survival and virulence of Vibrio cholerae. J Bacteriol 180:773–784. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Suh SJ, Silo-Suh L, Woods DE, Hassett DJ, West SE, Ohman DE. 1999. Effect of rpoS mutation on the stress response and expression of virulence factors in Pseudomonas aeruginosa. J Bacteriol 181:3890–3897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Hulsmann A, Rosche TM, Kong IS, Hassan HM, Beam DM, Oliver JD. 2003. RpoS-dependent stress response and exoenzyme production in Vibrio vulnificus. Appl Environ Microbiol 69:6114–6120. doi: 10.1128/AEM.69.10.6114-6120.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Gulig PA, Bourdage KL, Starks AM. 2005. Molecular pathogenesis of Vibrio vulnificus. J Microbiol 43(Spec no):118–131. [PubMed] [Google Scholar]
- 9.Jones MK, Oliver JD. 2009. Vibrio vulnificus: disease and pathogenesis. Infect Immun 77:1723–1733. doi: 10.1128/IAI.01046-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Horseman MA, Surani S. 2011. A comprehensive review of Vibrio vulnificus: an important cause of severe sepsis and skin and soft-tissue infection. Int J Infect Dis 15:e157–e166. doi: 10.1016/j.ijid.2010.11.003. [DOI] [PubMed] [Google Scholar]
- 11.Oliver JD. June 2015. The biology of Vibrio vulnificus. Microbiol Spectr 3. doi: 10.1128/microbiolspec.VE-0001-2014. [DOI] [PubMed] [Google Scholar]
- 12.Prasad C. 1995. Bioactive cyclic dipeptides. Peptides 16:151–164. doi: 10.1016/0196-9781(94)00017-Z. [DOI] [PubMed] [Google Scholar]
- 13.Huang R, Zhou X, Xu T, Yang X, Liu Y. 2010. Diketopiperazines from marine organisms. Chem Biodivers 7:2809–2829. doi: 10.1002/cbdv.200900211. [DOI] [PubMed] [Google Scholar]
- 14.Strom K, Sjogren J, Broberg A, Schnurer J. 2002. Lactobacillus plantarum MiLAB 393 produces the antifungal cyclic dipeptides cyclo(L-Phe-L-Pro) and cyclo(L-Phe-trans-4-OH-L-Pro) and 3-phenyllactic acid. Appl Environ Microbiol 68:4322–4327. doi: 10.1128/AEM.68.9.4322-4327.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Rhee KH. 2004. Cyclic dipeptides exhibit synergistic, broad spectrum antimicrobial effects and have anti-mutagenic properties. Int J Antimicrob Agents 24:423–427. doi: 10.1016/j.ijantimicag.2004.05.005. [DOI] [PubMed] [Google Scholar]
- 16.Kwak MK, Liu R, Kwon JO, Kim MK, Kim AH, Kang SO. 2013. Cyclic dipeptides from lactic acid bacteria inhibit proliferation of the influenza A virus. J Microbiol 51:836–843. doi: 10.1007/s12275-013-3521-y. [DOI] [PubMed] [Google Scholar]
- 17.Graz CJ, Grant GD, Brauns SC, Hunt A, Jamie H, Milne PJ. 2000. Cyclic dipeptides in the induction of maturation for cancer therapy. J Pharm Pharmacol 52:75–82. doi: 10.1211/0022357001773535. [DOI] [PubMed] [Google Scholar]
- 18.Brauns SC, Milne P, Naude R, Van de Venter M. 2004. Selected cyclic dipeptides inhibit cancer cell growth and induce apoptosis in HT-29 colon cancer cells. Anticancer Res 24:1713–1719. [PubMed] [Google Scholar]
- 19.Wang X, Huang Y, Sheng Y, Su P, Qiu Y, Ke C, Feng D. 2017. Antifouling activity towards mussel by small-molecule compounds from a strain of Vibrio alginolyticus bacterium associated with sea anemone Haliplanella sp. J Microbiol Biotechnol 27: 460–470. doi: 10.4014/jmb.1607.07068. [DOI] [PubMed] [Google Scholar]
- 20.Alshaibani M, Zin N, Jalil J, Sidik N, Ahmad SJ, Kamal N, Edrada-Ebel R. 2017. Isolation, purification, and characterization of five active diketopiperazine derivatives from endophytic Streptomyces SUK 25 with antimicrobial and cytotoxic activities. J Microbiol Biotechnol 27:1249–1256. doi: 10.4014/jmb.1608.08032. [DOI] [PubMed] [Google Scholar]
- 21.Park DK, Lee KE, Baek CH, Kim IH, Kwon JH, Lee WK, Lee KH, Kim BS, Choi SH, Kim KS. 2006. Cyclo(Phe-Pro) modulates the expression of ompU in Vibrio spp. J Bacteriol 188:2214–2221. doi: 10.1128/JB.188.6.2214-2221.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Klose KE. 2006. Increased chatter: cyclic dipeptides as molecules of chemical communication in Vibrio spp. J Bacteriol 188:2025–2026. doi: 10.1128/JB.188.6.2025-2026.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Bina XR, Taylor DL, Vikram A, Ante VM, Bina JE. 2013. Vibrio cholerae ToxR downregulates virulence factor production in response to cyclo(Phe-Pro). mBio 4:e00366-13. doi: 10.1128/mBio.00366-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Childers BM, Klose KE. 2007. Regulation of virulence in Vibrio cholerae: the ToxR regulon. Future Microbiol 2:335–344. doi: 10.2217/17460913.2.3.335. [DOI] [PubMed] [Google Scholar]
- 25.Weber GG, Klose KE. 2011. The complexity of ToxT-dependent transcription in Vibrio cholerae. Indian J Med Res 133:201–206. [PMC free article] [PubMed] [Google Scholar]
- 26.Zhang Y, Gao H, Osei-Adjei G, Yang W, Yang H, Yin Z, Huang X, Zhou D. 2017. Transcriptional regulation of the type VI secretion system 1 genes by quorum sensing and ToxR in Vibrio parahaemolyticus. Front Microbiol 8:2005. doi: 10.3389/fmicb.2017.02005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Morgan SJ, Felek S, Gadwal S, Koropatkin NM, Perry JW, Bryson AB, Krukonis ES. 2011. The two faces of ToxR: activator of ompU, co-regulator of toxT in Vibrio cholerae. Mol Microbiol 81:113–128. doi: 10.1111/j.1365-2958.2011.07681.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Aeckersberg F, Lupp C, Feliciano B, Ruby EG. 2001. Vibrio fischeri outer membrane protein OmpU plays a role in normal symbiotic colonization. J Bacteriol 183:6590–6597. doi: 10.1128/JB.183.22.6590-6597.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Mathur J, Waldor MK. 2004. The Vibrio cholerae ToxR-regulated porin OmpU confers resistance to antimicrobial peptides. Infect Immun 72:3577–3583. doi: 10.1128/IAI.72.6.3577-3583.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Wang SY, Lauritz J, Jass J, Milton DL. 2003. Role for the major outer-membrane protein from Vibrio anguillarum in bile resistance and biofilm formation. Microbiology 149:1061–1071. doi: 10.1099/mic.0.26032-0. [DOI] [PubMed] [Google Scholar]
- 31.Lee K, Jeong JE, Kim IH, Kim KS, Ju BG. 2015. Cyclo(phenylalanine-proline) induces DNA damage in mammalian cells via reactive oxygen species. J Cell Mol Med 19:2851–2864. doi: 10.1111/jcmm.12678. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Kim K, Kim NJ, Kim SY, Kim IH, Kim KS, Lee GR. 2015. Cyclo(Phe-Pro) produced by the human pathogen Vibrio vulnificus inhibits host innate immune responses through the NF-kappaB pathway. Infect Immun 83:1150–1161. doi: 10.1128/IAI.02878-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Staerck C, Gastebois A, Vandeputte P, Calenda A, Larcher G, Gillmann L, Papon N, Bouchara JP, Fleury MJJ. 2017. Microbial antioxidant defense enzymes. Microb Pathog 110:56–65. doi: 10.1016/j.micpath.2017.06.015. [DOI] [PubMed] [Google Scholar]
- 34.Park KJ, Kang MJ, Kim SH, Lee HJ, Lim JK, Choi SH, Park SJ, Lee KH. 2004. Isolation and characterization of rpoS from a pathogenic bacterium, Vibrio vulnificus: role of sigmaS in survival of exponential-phase cells under oxidative stress. J Bacteriol 186:3304–3312. doi: 10.1128/JB.186.11.3304-3312.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Furukawa T, Akutagawa T, Funatani H, Uchida T, Hotta Y, Niwa M, Takaya Y. 2012. Cyclic dipeptides exhibit potency for scavenging radicals. Bioorg Med Chem 20:2002–2009. doi: 10.1016/j.bmc.2012.01.050. [DOI] [PubMed] [Google Scholar]
- 36.Bozin B, Mimica-Dukic N, Samojlik I, Goran A, Igic R. 2008. Phenolics as antioxidants in garlic (Allium sativum L., Alliaceae). Food Chem 111:925–929. [Google Scholar]
- 37.Hengge-Aronis R. 2002. Signal transduction and regulatory mechanisms involved in control of the sigma(S) (RpoS) subunit of RNA polymerase. Microbiol Mol Biol Rev 66:373–395. doi: 10.1128/MMBR.66.3.373-395.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Kim IH, Son JS, Wen Y, Jeong SM, Min GY, Park NY, Lee KW, Cho YJ, Chun J, Kim KS. 2013. Transcriptomic analysis of genes modulated by cyclo(L-phenylalanine-L-proline) in Vibrio vulnificus. J Microbiol Biotechnol 23:1791–1801. doi: 10.4014/jmb.1308.08068. [DOI] [PubMed] [Google Scholar]
- 39.Kim JA, Park JH, Lee MA, Lee HJ, Park SJ, Kim KS, Choi SH, Lee KH. 2015. Stationary-phase induction of vvpS expression by three transcription factors: repression by LeuO and activation by SmcR and CRP. Mol Microbiol 97:330–346. doi: 10.1111/mmi.13028. [DOI] [PubMed] [Google Scholar]
- 40.Vijayakumar SRV, Kirchhof MG, Patten CL, Schellhorn HE. 2004. RpoS-regulated genes of Escherichia coli identified by random lacZ fusion mutagenesis. J Bacteriol 186:8499–8507. doi: 10.1128/JB.186.24.8499-8507.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Jeong HS, Jeong KC, Choi HK, Park KJ, Lee KH, Rhee JH, Choi SH. 2001. Differential expression of Vibrio vulnificus elastase gene in a growth phase-dependent manner by two different types of promoters. J Biol Chem 276:13875–13880. doi: 10.1074/jbc.M010567200. [DOI] [PubMed] [Google Scholar]
- 42.Sharma AK, Payne SM. 2006. Induction of expression of hfq by DksA is essential for Shigella flexneri virulence. Mol Microbiol 62:469–479. doi: 10.1111/j.1365-2958.2006.05376.x. [DOI] [PubMed] [Google Scholar]
- 43.Grove A. 2011. Functional evolution of bacterial histone-like HU proteins. Curr Issues Mol Biol 13:1–12. [PubMed] [Google Scholar]
- 44.Balandina A, Kamashev D, Rouviere-Yaniv J. 2002. The bacterial histone-like protein HU specifically recognizes similar structures in all nucleic acids. DNA, RNA, and their hybrids. J Biol Chem 277:27622–27628. [DOI] [PubMed] [Google Scholar]
- 45.Dame RT, Goosen N. 2002. HU: promoting or counteracting DNA compaction? FEBS Lett 529:151–156. doi: 10.1016/S0014-5793(02)03363-X. [DOI] [PubMed] [Google Scholar]
- 46.Dorman CJ, Deighan P. 2003. Regulation of gene expression by histone-like proteins in bacteria. Curr Opin Genet Dev 13:179–184. doi: 10.1016/S0959-437X(03)00025-X. [DOI] [PubMed] [Google Scholar]
- 47.Morales P, Rouviere-Yaniv J, Dreyfus M. 2002. The histone-like protein HU does not obstruct movement of T7 RNA polymerase in Escherichia coli cells but stimulates its activity. J Bacteriol 184:1565–1570. doi: 10.1128/JB.184.6.1565-1570.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Balandina A, Claret L, Hengge-Aronis R, Rouviere-Yaniv J. 2001. The Escherichia coli histone-like protein HU regulates rpoS translation. Mol Microbiol 39:1069–1079. doi: 10.1046/j.1365-2958.2001.02305.x. [DOI] [PubMed] [Google Scholar]
- 49.Macvanin M, Edgar R, Cui F, Trostel A, Zhurkin V, Adhya S. 2012. Noncoding RNAs binding to the nucleoid protein HU in Escherichia coli. J Bacteriol 194:6046–6055. doi: 10.1128/JB.00961-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Dillon SC, Espinosa E, Hokamp K, Ussery DW, Casadesus J, Dorman CJ. 2012. LeuO is a global regulator of gene expression in Salmonella enterica serovar Typhimurium. Mol Microbiol 85:1072–1089. doi: 10.1111/j.1365-2958.2012.08162.x. [DOI] [PubMed] [Google Scholar]
- 51.Hernandez-Lucas I, Calva E. 2012. The coming of age of the LeuO regulator. Mol Microbiol 85:1026–1028. doi: 10.1111/j.1365-2958.2012.08175.x. [DOI] [PubMed] [Google Scholar]
- 52.Kim IH, Wen Y, Son JS, Lee KH, Kim KS. 2013. The fur-iron complex modulates expression of the quorum-sensing master regulator, SmcR, to control expression of virulence factors in Vibrio vulnificus. Infect Immun 81:2888–2898. doi: 10.1128/IAI.00375-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Simon R, Priefer U, Pühler A. 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram negative bacteria. Nat Biotechnol 1:784–791. doi: 10.1038/nbt1183-784. [DOI] [Google Scholar]
- 54.Milton DL, O'Toole R, Horstedt P, Wolf-Watz H. 1996. Flagellin A is essential for the virulence of Vibrio anguillarum. J Bacteriol 178:1310–1319. doi: 10.1128/jb.178.5.1310-1319.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Keen NT, Tamaki S, Kobayashi D, Trollinger D. 1988. Improved broad-host-range plasmids for DNA cloning in gram-negative bacteria. Gene 70:191–197. doi: 10.1016/0378-1119(88)90117-5. [DOI] [PubMed] [Google Scholar]
- 56.Kovach ME, Elzer PH, Hill DS, Robertson GT, Farris MA, Roop RM II, Peterson KM. 1995. Four new derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes. Gene 166:175–176. doi: 10.1016/0378-1119(95)00584-1. [DOI] [PubMed] [Google Scholar]
- 57.de Lorenzo V, Herrero M, Jakubzik U, Timmis KN. 1990. Mini-Tn5 transposon derivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in gram-negative eubacteria. J Bacteriol 172:6568–6572. doi: 10.1128/jb.172.11.6568-6572.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Miller JH. 1972. Assay of β-galactosidase, p 352–355. In Miller JH. (ed), Experiments in molecular genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. [Google Scholar]
- 59.Kim IH, Kim IJ, Wen Y, Park NY, Park J, Lee KW, Koh A, Lee JH, Koo SH, Kim KS. 2015. Vibrio vulnificus secretes an insulin-degrading enzyme that promotes bacterial proliferation in vivo. J Biol Chem 290:18708–18720. doi: 10.1074/jbc.M115.656306. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.